1)特殊ミルク共同安全開発委員会.フェニルケトン尿症(高フェニルアラニン血症の一部を含む)治療指針の第2次改定の経緯と改定勧告治療指針(平成24年度)について.特殊ミルク情報(先天性代謝異常症の治療).2012; 11: 82-4
|
|
|
2)Feillet F, van Spronsen FJ, MacDonald A, et al. Challenges and pitfalls in the management of phenylketonuria. Pediatrics. 2010; 126: 333-41
|
|
|
3)Webster D, Wildgoose J. Tyrosine supplementation for phenylketonuria. Cochrane Database Syst Rev. CD001507
|
|
|
4)Antoshechkin AG, Chentsova TV, Tatur V, et al. Content of phenylalanine, tyrosine and their metabolites in CSF in phenylketonuria. J Inherit Metab Dis. 1991; 14: 749-54
|
|
|
5)Dyer CA, Kendler A, Philibotte T, et al. Evidence for central nervous system glial cell plasticity in phenylketonuria. J Neuropathol Exp Neurol. 1996; 55: 795-814
|
|
|
6)Martynyuk AE, Glushakov AV, Sumners C, et al. Impaired glutamatergic synaptic transmission in the PKU brain. Mol Genet Metab. 2005; 86 Suppl 1: S34-42
|
|
|
7)Shefer S, Tint GS, Jean-Guillaume D, et al. Is there a relationship between 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and forebrain pathology in the PKU mouse? J Neurosci Res. 2000; 61: 549-63
|
|
|
8)Wasserstein MP, Snyderman SE, Sansaricq C, et al. Cerebral glucose metabolism in adults with early treated classic phenylketonuria. Mol Genet Metab. 2006; 87: 272-7
|
|
|
9)Hoeks MP, den Heijer M, Janssen MC. Adult issues in phenylketonuria. Neth J Med. 2009; 67: 2-7
|
|
|
10)Trefz F, Maillot F, Motzfeldt K, et al. Adult phenylketonuria outcome and management. Mol Genet Metab. 2011; 104 Suppl: S26-30
|
|
|
11)Hanley WB. Adult phenylketonuria. Am J Med. 2004; 117: 590-5
|
|
|
12)Weglage J, Funders B, Wilken B, Schubert D, Ullrich K. School performance and intellectual outcome in adolescents with phenylketonuria. Acta Paediatr. 1993; 82: 582-6
|
|
|
13)Waisbren SE, Brown MJ, de Sonneville LM, et al. Review of neuropsychological functioning in treated phenylketonuria: an information processing approach. Acta Paediatr Suppl. 1994; 407: 98-103
|
|
|
14)岡野 善.フェニルケトン尿症.小児内科.2011; 43: 1509-11
|
|
|
15)Schmidt E, Rupp A, Burgard P, et al. Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level. J Clin Exp Neuropsychol. 1994; 16: 681-8
|
|
|
16)Seashore MR, Friedman E, Novelly RA, et al. Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenyl-alanine restriction. Pediatrics. 1985; 75: 226-32
|
|
|
17)Cabalska B, Duczynska N, Borzymowska J, et al. Termination of dietary treatment in phenylketonuria. Eur J Pediatr. 1977; 126: 253-62
|
|
|
18)和泉 美,山崎 弘,大和田操.フェニルケトン尿症における脳波の検討.日本小児科学会雑誌.2004; 108: 1366-71
|
|
|
19)Kono K, Okano Y, Nakayama K, et al. Diffusion-weighted MR imaging in patients with phenyl-ketonuria: relationship between serum phenyl-alanine levels and ADC values in cerebral white matter. Radiology. 2005; 236: 630-6
|
|
|
20)Cleary MA, Walter JH, Wraith JE, et al. Magnetic resonance imaging of the brain in phenylketonuria. Lancet. 1994; 344: 87-90
|
|
|
21)Sener RN. Diffusion MRI findings in phenylketonuria. Eur Radiol. 2003; 13 Suppl 6: L226-9
|
|
|
22)Thompson AJ, Smith I, Brenton D, et al. Neurological deterioration in young adults with phenylketonuria. Lancet. 1990; 336: 602-5
|
|
|
23)Pietz J, Dunckelmann R, Rupp A, et al. Neurological outcome in adult patients with early-treated phenylketonuria. Eur J Pediatr. 1998; 157: 824-30
|
|
|
24)McCombe PA, McLaughlin DB, Chalk JB, et al. Spasticity and white matter abnormalities in adult phenylketonuria. J Neurol Neurosurg Psychiatry. 1992; 55: 359-61
|
|
|
25)Koch R, Burton B, Hoganson G, et al. Phenyl-ketonuria in adulthood: a collaborative study. J Inherit Metab Dis. 2002; 25: 333-46
|
|
|
26)Villasana D, Butler IJ, Williams JC, et al. Neurological deterioration in adult phenylketonuria. J Inherit Metab Dis. 1989; 12: 451-7
|
|
|
27)Waisbren SE, Levy HL. Agoraphobia in phenylketonuria. J Inherit Metab Dis. 1991; 14: 755-64
|
|
|
28)Weglage J, Funders B, Wilken B, et al. Psychological and social findings in adolescents with phenylketonuria. Eur J Pediatr. 1992; 151: 522-5
|
|
|
29)Guttler F, Lou H. Dietary problems of phenylketonuria: effect on CNS transmitters and their possible role in behaviour and neuropsychological function. J Inherit Metab Dis. 1986; 9 Suppl 2: 169-77
|
|
|
30)Charney DS, Heninger GR. Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry. 1986; 43: 1042-54
|
|
|
31)Sanayama Y, Nagasaka H, Takayanagi M, et al. Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria. Mol Genet Metab. 2011; 103: 220-5
|
|
|
32)岡野 善.成人フェニルケトン尿症の血中フェニルアラニン値のコントロールはいくらであるべきか.特殊ミルク情報(先天性代謝異常症の治療).2011; 11: 20-4
|
|
|
33)Sitta A, Vanzin CS, Biancini GB, et al. Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients. Cell Mol Neurobiol. 2011; 31: 429-36
|
|
|
34)Robinson M, White FJ, Cleary MA, et al. Increased risk of vitamin B12 deficiency in patients with phenylketonuria on an unrestricted or relaxed diet. J Pediatr. 2000; 136: 545-7
|
|
|
35)Modan-Moses D, Vered I, Schwartz G, et al. Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis. 2007; 30: 202-8
|
|
|
36)Allen JR, Humphries IR, Waters DL, et al. Decreased bone mineral density in children with phenylketonuria. Am J Clin Nutr. 1994; 59: 419-22
|
|
|
37)Nagasaka H, Tsukahara H, Takatani T, et al. Cross-sectional study of bone metabolism with nutrition in adult classical phenylketonuric patients diagnosed by neonatal screening. J Bone Miner Metab. 2011; 29: 737-43
|
|
|
38)Scarabino T, Popolizio T, Tosetti M, et al. Phenylketonuria: white-matter changes assessed by 3. 0-T magnetic resonance (MR) imaging, MR spectro-scopy and MR diffusion. Radiol Med. 2009; 114: 461-74
|
|
|
39)Anderson PJ, Leuzzi V. White matter pathology in phenylketonuria. Mol Genet Metab. 2010; 99 Suppl 1: S3-9
|
|
|
40)Bick U, Ullrich K, Stober U, et al. White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings. Eur J Pediatr. 1993; 152: 1012-20
|
|
|
41)Pietz J, Meyding-Lamade UK, Schmidt H. Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency. Eur J Pediatr. 1996; 155 Suppl 1: S69-73
|
|
|
42)Phillips MD, McGraw P, Lowe MJ, et al. Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria. AJNR Am J Neuroradiol. 2001; 22: 1583-6
|
|
|
43)Dezortova M, Hajek M, Tintera J, et al. MR in phenylketonuria-related brain lesions. Acta Radiol. 2001; 42: 459-66
|
|
|
44)Cleary MA, Walter JH, Wraith JE, et al. Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J Pediatr. 1995; 127: 251-5
|
|
|
45)Leuzzi V, Tosetti M, Montanaro D, et al. The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1H MRS) study. J Inherit Metab Dis. 2007; 30: 209-16
|
|
|
46)Ullrich K, Weglage J, Schuierer G, et al. Cranial MRI in PKU: evaluation of a critical threshold for blood phenylalanine. Neuropediatrics. 1994; 25: 278-9
|
|
|
47)Sijens PE, Oudkerk M, Reijngoud DJ, et al. 1H MR chemical shift imaging detection of phenylalanine in patients suffering from phenylketonuria (PKU). Eur Radiol. 2004; 14: 1895-900
|
|
|
48)Moats RA, Moseley KD, Koch R, et al. Brain phenylalanine concentrations in phenylketonuria: research and treatment of adults. Pediatrics. 2003; 112(6 Pt 2): 1575-9
|
|
|
49)Knox WE. An evaluation of the treatment of phenylketonuria with diets low in phenylalanine. Pediatrics. 1960; 26: 1-11
|
|
|
50)Horner FA, Streamer CW, Alejandrino LL, et al. Termination of dietary treatment of phenylketonuria. N Engl J Med. 1962; 266: 79-81
|
|
|
51)Holtzman NA, Welcher DW, Mellits ED. Termination of restricted diet in children with phenylketonuria: a randomized controlled study. N Engl J Med. 1975; 293: 1121-4
|
|
|
52)National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16-18, 2000. Pediatrics. 2001; 108: 972-82
|
|
|
53)芳野 信,渡邊 順,岡田 純.成人フェニルケトン尿症患者の医療的・社会的アウトカム.特殊ミルク情報(先天性代謝異常症の治療).2011; 11: 6-7
|
|
|
54)呉 繁.アミノ酸代謝異常症 フェニルケトン尿症.小児内科.2012; 44: 1619-22
|
|
|
55)Kure S, Hou DC, Ohura T, et al. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. J Pediatr. 1999; 135: 375-8
|
|
|
56)Shintaku H, Kure S, Ohura T, et al. Long-term treatment and diagnosis of tetrahydrobiopterin-responsive hyperphenylalaninemia with a mutant phenylalanine hydroxylase gene. Pediatr Res. 2004; 55: 425-30
|
|
|